NIH: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trial Required) RFA-CA-19-056
Sponsor: NIHInternal Deadline: 10/22/2019Institutional Submission Limit: 1Sponsor Deadline: 01/10/2020Program WebsiteNIH: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trial Required) RFA-CA-19-056
This funding opportunity announcement (FOA) invites applications from institutions/organizations that propose to enable the provision of support for AIDS Malignancy Consortium (AMC).
USC may only submit only one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (email@example.com) by October 22, 2019. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is NOT REQUIRED and a completed application is due by January 10, 2020. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-056.html